Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019
Headlines have led to outside-the-box thinking as well as a more global perspective in preventing CV disease and events.
Related Articles
AHA Offers a Primer on Alcohol’s CV Impact, Areas of Uncertainty
Alcohol is a hot topic—the new statement sums up the evidence and provides ways to help patients understand the risks.
Troponin Spikes After Exercise Not Linked to CAD in Middle-aged Athletes
Release of cardiac troponin after intense endurance exercise is common, but it doesn’t signal occult disease.
Lower Mortality for AF Patients When Surgical Ablation Added to CABG: Medicare
Outcomes in the observational study were better among patients treated by surgeons who regularly do ablations.
Greater Frailty Means More Complications, Higher Mortality After PCI
Clinicians should assess frailty more formally before PCI, so the knowledge can help guide discussions with patients, say experts.
Acute Coronary Care in Ethiopia
Mamas Mamas talks to Tesfaye Telila about the landscape of acute coronary care in Ethiopa, where just a few dozen cardiologists contend with a population…
Simple Sitting-Rising Test Linked to Natural and CV Mortality
The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age.
Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms
Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI platforms.
‘Sobering’ Adverse Event Rate With Evoque Seen in Real-world Use
Responding to MAUDE data, some have safety concerns but others aren’t surprised to see more events in higher-risk patients.